Xiaoni Shao

486 total citations
11 papers, 383 citations indexed

About

Xiaoni Shao is a scholar working on Molecular Biology, Nephrology and Pharmacology. According to data from OpenAlex, Xiaoni Shao has authored 11 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Nephrology and 3 papers in Pharmacology. Recurrent topics in Xiaoni Shao's work include Gout, Hyperuricemia, Uric Acid (6 papers), Metabolomics and Mass Spectrometry Studies (3 papers) and Pharmacological Effects of Natural Compounds (3 papers). Xiaoni Shao is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (6 papers), Metabolomics and Mass Spectrometry Studies (3 papers) and Pharmacological Effects of Natural Compounds (3 papers). Xiaoni Shao collaborates with scholars based in China. Xiaoni Shao's co-authors include Yinglan Zhao, Xiaobo Cen, Zeping Zuo, Fabao Gao, Jing Hu, Pengchi Deng, Jing Hu, Wenjie Lu, Liang Wang and Tianming Wu and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and Scientific Reports.

In The Last Decade

Xiaoni Shao

11 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoni Shao China 8 223 99 90 40 37 11 383
Anni Song China 9 142 0.6× 34 0.3× 119 1.3× 58 1.4× 46 1.2× 16 424
Mengqi Su China 10 212 1.0× 73 0.7× 24 0.3× 42 1.1× 48 1.3× 19 431
Andrej Veljković Serbia 13 159 0.7× 28 0.3× 46 0.5× 41 1.0× 44 1.2× 43 465
Dongjie Wang China 10 247 1.1× 69 0.7× 73 0.8× 15 0.4× 88 2.4× 27 452
Xia Zhong China 10 150 0.7× 23 0.2× 89 1.0× 42 1.1× 26 0.7× 24 359
Alfredo Briones‐Herrera Mexico 11 196 0.9× 35 0.4× 50 0.6× 39 1.0× 25 0.7× 13 342
Jichen Sha China 9 197 0.9× 33 0.3× 61 0.7× 67 1.7× 24 0.6× 15 457
Anu Shah United States 8 268 1.2× 31 0.3× 74 0.8× 63 1.6× 83 2.2× 12 486
Qichang Xing China 9 145 0.7× 34 0.3× 25 0.3× 41 1.0× 25 0.7× 21 307
Wensong Zhang China 10 228 1.0× 41 0.4× 17 0.2× 51 1.3× 38 1.0× 22 461

Countries citing papers authored by Xiaoni Shao

Since Specialization
Citations

This map shows the geographic impact of Xiaoni Shao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoni Shao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoni Shao more than expected).

Fields of papers citing papers by Xiaoni Shao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoni Shao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoni Shao. The network helps show where Xiaoni Shao may publish in the future.

Co-authorship network of co-authors of Xiaoni Shao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoni Shao. A scholar is included among the top collaborators of Xiaoni Shao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoni Shao. Xiaoni Shao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Yang, Xiujuan, Bing Han, Linyan Wei, et al.. (2025). Taurine alleviates hyperuricemia-induced nephropathy in rats: insights from microbiome and metabolomics. Frontiers in Nutrition. 12. 1587198–1587198. 1 indexed citations
3.
Li, Na, et al.. (2022). Whole transcriptome expression profiles in kidney samples from rats with hyperuricaemic nephropathy. PLoS ONE. 17(12). e0276591–e0276591. 4 indexed citations
5.
Shao, Xiaoni, et al.. (2021). Targeting Signaling Pathway Networks in Several Malignant Tumors: Progresses and Challenges. Frontiers in Pharmacology. 12. 675675–675675. 28 indexed citations
6.
Zuo, Zeping, Miaomiao Chen, Xiaoni Shao, et al.. (2019). Design and biological evaluation of tetrahydropyridine derivatives as novel human GPR119 agonists. Bioorganic & Medicinal Chemistry Letters. 30(4). 126855–126855. 7 indexed citations
7.
Li, Yan, Chunting Wang, Dandan Li, et al.. (2017). 1H-NMR-based metabolic profiling of a colorectal cancer CT-26 lung metastasis model in mice. Oncology Reports. 38(5). 3044–3054. 13 indexed citations
8.
Shao, Xiaoni, Wenjie Lu, Fabao Gao, et al.. (2016). Uric Acid Induces Cognitive Dysfunction through Hippocampal Inflammation in Rodents and Humans. Journal of Neuroscience. 36(43). 10990–11005. 59 indexed citations
9.
Lu, Wenjie, Youzhi Xu, Xiaoni Shao, et al.. (2015). Uric Acid Produces an Inflammatory Response through Activation of NF-κB in the Hypothalamus: Implications for the Pathogenesis of Metabolic Disorders. Scientific Reports. 5(1). 12144–12144. 69 indexed citations
10.
Wang, Liang, Longqi Chen, Pengchi Deng, et al.. (2013). 1H-NMR based metabonomic profiling of human esophageal cancer tissue. Molecular Cancer. 12(1). 25–25. 73 indexed citations
11.
Wang, Huijuan, Liang Wang, Hailong Zhang, et al.. (2013). ¹H NMR-based metabolic profiling of human rectal cancer tissue. Molecular Cancer. 12(1). 121–121. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026